160 related articles for article (PubMed ID: 15604890)
1. Novel strategies for steroid-refractory acute graft-versus-host disease.
Bolaños-Meade J; Vogelsang GB
Curr Opin Hematol; 2005 Jan; 12(1):40-4. PubMed ID: 15604890
[TBL] [Abstract][Full Text] [Related]
2. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.
Alousi AM; Weisdorf DJ; Logan BR; Bolaños-Meade J; Carter S; Difronzo N; Pasquini M; Goldstein SC; Ho VT; Hayes-Lattin B; Wingard JR; Horowitz MM; Levine JE;
Blood; 2009 Jul; 114(3):511-7. PubMed ID: 19443659
[TBL] [Abstract][Full Text] [Related]
3. Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation.
Kim SS
Ann Pharmacother; 2007 Sep; 41(9):1436-44. PubMed ID: 17684033
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.
Bolaños-Meade J; Wu J; Logan BR; Levine JE; Ho VT; Alousi AM; Weisdorf DJ; Luznik L;
Biol Blood Marrow Transplant; 2013 Mar; 19(3):481-5. PubMed ID: 23247045
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-
Shen MZ; Li JX; Zhang XH; Xu LP; Wang Y; Liu KY; Huang XJ; Hong SD; Mo XD
Front Immunol; 2021; 12():749266. PubMed ID: 34621279
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ho VT; Zahrieh D; Hochberg E; Micale E; Levin J; Reynolds C; Steckel S; Cutler C; Fisher DC; Lee SJ; Alyea EP; Ritz J; Soiffer RJ; Antin JH
Blood; 2004 Aug; 104(4):1224-6. PubMed ID: 15113758
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hattori K; Doki N; Kurosawa S; Hino Y; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2017 Feb; 96(2):319-321. PubMed ID: 27766393
[No Abstract] [Full Text] [Related]
8. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Greinix HT; Worel N; Knobler R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
[No Abstract] [Full Text] [Related]
9. Chronic graft-versus-host disease.
Bolaños-Meade J; Vogelsang GB
Curr Pharm Des; 2008; 14(20):1974-86. PubMed ID: 18691108
[TBL] [Abstract][Full Text] [Related]
10. Update on the management of acute graft-versus-host disease.
Bolaños-Meade J
Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
12. Nonmyeloablative transplants: preclinical and clinical results.
Sandmaier BM; McSweeney P; Yu C; Storb R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):78-81. PubMed ID: 10877058
[TBL] [Abstract][Full Text] [Related]
13. Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.
Shaughnessy PJ; Bachier C; Grimley M; Freytes CO; Callander NS; Essell JH; Flomenberg N; Selby G; Lemaistre CF
Biol Blood Marrow Transplant; 2005 Mar; 11(3):188-93. PubMed ID: 15744237
[TBL] [Abstract][Full Text] [Related]
14. Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody.
Chakupurakal G; García-Márquez MA; Shimabukuro-Vornhagen A; Theurich S; Holtick U; Hallek M; Scheid C; von Bergwelt-Baildon M
Eur J Haematol; 2016 Aug; 97(2):121-7. PubMed ID: 26492560
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
[TBL] [Abstract][Full Text] [Related]
16. Autologous graft-versus-host disease after denileukin diftitox and autologous stem cell transplantation for refractory T-cell lymphoma.
Zalom M; Lill M; Lukic D; Balzer BL; Lim S
Leuk Lymphoma; 2009 Jan; 50(1):124-6. PubMed ID: 19117212
[No Abstract] [Full Text] [Related]
17. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.
Baird K; Wayne AS
Transfus Apher Sci; 2009 Dec; 41(3):209-16. PubMed ID: 19819186
[TBL] [Abstract][Full Text] [Related]
19. Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation.
Yamane T; Yamamura R; Aoyama Y; Nakamae H; Hasegawa T; Sakamoto C; Shibata H; Terada Y; Koh G; Hino M
Leuk Lymphoma; 2003 Dec; 44(12):2095-7. PubMed ID: 14959853
[TBL] [Abstract][Full Text] [Related]
20. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB
Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
